Top Rheumatoid Arthritis News
Keep up to date on all the latest Rheumatoid Arthritis research, drugs, and treatment.
-
Glucosamine doesn't prevent joint damage: study
University of Pittsburgh researchers say the popular arthritis supplement glucosamine does not prevent joint damage in patients with osteoarthritis. Read Summary > -
FDA offers advice on medication disposal
The site gives particular emphasis to the disposal of opioid painkillers, which can be harmful or deadly if taken by someone other than the person for whom they were prescribed. Read Summary > -
Actemra helps halt RA progress: study
The rheumatoid arthritis (RA) drug Actemra helps halt the progression of joint damage in people with the condition when combined with the standard treatment of methotrexate, a new study has found. Read Summary > -
Exercise may help RA patients
A review of previous studies involving 575 patients with rheumatoid arthritis has found that patients with this condition may benefit from exercise programs that improve strength and stamina. Read Summary > -
Use of Rituxan by early RA sufferers rejected
The use of the rheumatoid arthritis (RA) drug Rituxan by people in the early stages of the disease has been rejected by U.S. health regulators. Read Summary > -
FDA approves RA testing kits
The kit is designed to identify antibodies to cyclic citrullinated peptides (anti-CCP), which appear in the blood long before the onset of RA symptoms. Read Summary > -
New RA drug meets goals in new trial
The drug is one of new class of drugs known as oral JAK inhibitors, which are being tested for their effects on enzymes linked to inflammatory and autoimmune diseases. Read Summary > -
Copper, magnetic bracelets don't help arthritis pain: study
British researchers say that copper and magnetic bracelets marketed to relieve arthritis pain don't actually help improve arthritis patients' joint discomfort, stiffness, or physical function. Read Summary >
